Probing the Mesenchymal Stem Cell Aging through In silico Assessment of Extracellular Vesicle-mediated miRNAs

Ningning Mi1, Xibin Liu2, Yuhua Gao3

  • 1College of Animal Science and Technology, College of Veterinary Medicine, Zhejiang A&F University, Linan, P.R. China.

PubMed
Abstract

Insights

Mesenchymal stem cell (MSC) aging, linked to human aging, involves changes in extracellular vesicle microRNAs (EV-miRNAs). Specific EV-miRNAs can predict MSC aging during culture, offering insights into cell therapy and aging processes.

Area of Science:

  • Cell Biology
  • Gerontology
  • Biotechnology

Background:

  • Mesenchymal stem cell (MSC) aging reduces proliferation and regeneration, contributing to human aging.
  • MSC aging is influenced by genetic, metabolic, and environmental factors.
  • In vitro MSC aging presents challenges for cell-based therapies.

Purpose of the Study:

  • To identify key extracellular vesicle microRNAs (EV-miRNAs) associated with mesenchymal stem cell (MSC) aging.
  • To explore the relationship between EV-miRNAs and the aging process of MSCs in vitro.
  • To establish a predictive model for MSC aging using EV-miRNA profiles.

Main Methods:

  • Analysis of Gene Expression Omnibus (GEO) datasets for mRNA and microRNA (miRNA) expression changes in aged MSCs.
  • Screening for correlations between extracellular vesicle (EV)-miRNAs and MSC aging.
  • Identification of differentially expressed EV-miRNAs (hsa-miR-146a-5p, hsa-miR-432-5p, hsa-miR-7706, hsa-miR-409-3p, hsa-miR-17-5p).

Main Results:

  • Significant differences in specific EV-miRNAs were observed between young and aged MSCs.
  • Signaling pathways like FOXO and P53 were activated post-aging, promoting the expression of identified EV-miRNAs.
  • These miRNAs are packaged into EVs via binding to RNA-binding proteins (A2BP1, SFRS2, MBNL1, EIF4B, ACO1).

Conclusions:

  • Specific EV-miRNAs serve as reliable biomarkers for predicting MSC aging in culture.
  • Understanding EV-miRNA dynamics offers potential therapeutic targets for age-related diseases.
  • This research provides a foundation for developing cell therapy strategies that account for MSC aging.